Geode Capital Management
CTOR icon

Geode Capital Management’s Citius Oncology CTOR Stock Holding History

Geode Capital Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$285K Buy
281,929
+36,522
+15% +$28.6K ﹤0.01% 3754
2026
Q2 		$160K Sell
245,407
-19,326
-7% -$15.4K ﹤0.01% 3984
2026
Q1 		$164K Buy
264,733
+44,686
+20% +$44.9K ﹤0.01% 3987
2025
Q4 		$220K Buy
220,047
+52,875
+32% +$75.8K ﹤0.01% 3868
2025
Q3 		$339K Buy
167,172
+109,875
+192% +$238K ﹤0.01% 3749
2025
Q2 		$249K Buy
57,297
+36,758
+179% +$42.9K ﹤0.01% 3800
2025
Q1 		$19.1K Buy
20,539
+7,888
+62% +$8.45K ﹤0.01% 4356
2024
Q4 		$14.5K Buy
+12,651
New +$14.2K ﹤0.01% 4408

Other funds holding CTOR

IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Geode Capital Management's CTOR Position: Q3 2026 in Review

Geode Capital Management increased its Citius Oncology (CTOR) stake by 15% in Q3 2026, buying an estimated $28.6K and bringing the position to 281,929 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #3754.

Geode Capital Management first reported a position in CTOR in Q4 2024 and has held it in 8 quarters since. The position peaked at $339K in Q3 2025. 7 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.

  • Geode Capital Management held 281,929 shares of Citius Oncology worth $285K as of Q3 2026.
  • Geode Capital Management bought 36,522 Citius Oncology shares in Q3 2026, an estimated $28.6K.
  • Citius Oncology made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3754 holding.
  • Geode Capital Management first reported a position in Citius Oncology in Q4 2024 and has held it in 8 quarters since.
  • Geode Capital Management's Citius Oncology position peaked at $339K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.